Living clinical guidelines for stroke: updates, challenges and opportunities

Continued growth in the number of published clinical studies has necessitated changes to the way evidencebased resources such as clinical guidelines are developed and updated. The Australian and New Zealand Clinical Guidelines for Stroke Management (https://infor mme.org.au/guide lines/ clini cal-guide lines-for-stroke-manag ement) are based on continual evidence surveillance and timely updates to recommendations as new research is published. In this article, we outline the main updates to recommendations since the guidelines moved into a living mode in 2018, and discuss key challenges and benefits of living guidelines.

[1]  S. McDonald,et al.  Feasibility of national living guideline methods: the Australian Stroke Guidelines , 2021, Journal of Clinical Epidemiology.

[2]  Amanda J. Patterson,et al.  The role of diet in secondary stroke prevention , 2020, The Lancet Neurology.

[3]  K. Leder,et al.  Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19 , 2020, Journal of Clinical Epidemiology.

[4]  I. Widyahening,et al.  Telestroke strategies to enhance acute stroke management in rural settings: A systematic review and meta‐analysis , 2020, Brain and behavior.

[5]  G. Hankey,et al.  Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial , 2020, The Lancet Neurology.

[6]  Thanh T. Tran,et al.  Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial , 2020, The Lancet Neurology.

[7]  S. Johnston,et al.  Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. , 2020, The New England journal of medicine.

[8]  P. Neužil,et al.  Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[9]  G. Donnan,et al.  Improving acute stroke care in regional hospitals: clinical evaluation of the Victorian Stroke Telemedicine program , 2020, The Medical journal of Australia.

[10]  T. Turner,et al.  Breathing life into Australian diabetes clinical guidelines , 2020, The Medical journal of Australia.

[11]  E. Vicaut,et al.  A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. , 2019, The New England journal of medicine.

[12]  Susan L Norris,et al.  Developing and applying a 'living guidelines' approach to WHO recommendations on maternal and perinatal health , 2019, BMJ Global Health.

[13]  Geoffrey A. Donnan,et al.  Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data , 2019, The Lancet.

[14]  Ashutosh Kumar Singh,et al.  Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial , 2019, Lancet.

[15]  J. Jeng,et al.  Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke , 2019, The New England journal of medicine.

[16]  C. Xue,et al.  Acupuncture for Post-stroke Shoulder-Hand Syndrome: A Systematic Review and Meta-Analysis , 2019, Front. Neurol..

[17]  G. Guyatt,et al.  Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis , 2018, British Medical Journal.

[18]  Heather B. Roesly.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging , 2018, The Journal of Emergency Medicine.

[19]  G. Chatellier,et al.  Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta‐Analysis, and New Insights From the CLOSE Study , 2018, Journal of the American Heart Association.

[20]  C. Gerloff,et al.  MRI‐Guided Thrombolysis for Stroke with Unknown Time of Onset , 2018, The New England journal of medicine.

[21]  Nima Zamiri,et al.  Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis , 2018, The Lancet.

[22]  M. Krause,et al.  Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke , 2018, The New England journal of medicine.

[23]  L. Ada,et al.  Progressive resistance training increases strength after stroke but this may not carry over to activity: a systematic review. , 2018, Journal of physiotherapy.

[24]  S. Kanneganti.  Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke , 2017 .

[25]  John L.P. Thompson,et al.  Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials , 2016, International journal of stroke : official journal of the International Stroke Society.

[26]  N. Lannin,et al.  Telerehabilitation services for stroke. , 2013, The Cochrane database of systematic reviews.